Header image

Publikace
Published in Top 10% journals in the field
The isocyanide SN2 reaction.
Nature Communications.
2023,
14(1),
5807,
ISSN: 2041-1723,
PMID: 37726293,
Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells.
European Journal of Medicinal Chemistry.
2023,
261,
115790,
ISSN: 0223-5234 ,
PMID: 37690264,
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors.
Journal of Medicinal Chemistry.
2023,
66(14),
9577-9591,
ISSN: 0022-2623,
PMID: 37450644,
2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling.
European Journal of Medicinal Chemistry.
2023,
258,
115610,
ISSN: 0223-5234,
PMID: 37437350,
[68Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography.
Journal of Medicinal Chemistry.
2023,
ISSN: 0022-2623,
PMID: 37252893,
Randomizing for Alzheimer's disease drug trials should consider the cancer history of participants.
Brain.
2023,
ISSN: 0006-8950,
PMID: 37243427,
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET.
Cell Death and Differentiation.
2023,
ISSN: 1350-9047,
PMID: 37142656,
Cannabis-derived products antagonize platinum drugs by altered cellular transport.
Biomedicine & Pharmacotherapy.
2023,
163,
114801,
ISSN: 0753-3322,
PMID: 37137184,
Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone).
European Journal of Medicinal Chemistry.
2023,
252,
115304,
ISSN: 0223-5234,
PMID: 37001390,
A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).
Expert Opinion on Therapeutic Patents.
2023,
33(2),
67-87,
ISSN: 1354-3776,
PMID: 36975020,